The South and Central America Cancer Targeted Therapy Market is expanding as healthcare systems increasingly adopt precision-based cancer treatment and advanced oncology solutions. The South and Central America Cancer Targeted Therapy Market size is expected to reach US$ 10,151.9 million by 2031 from US$ 4,725.4 million in 2024. The market is estimated to record a CAGR of 11.6% from 2025 to...